153 related articles for article (PubMed ID: 12714270)
21. Differentiation of human mesenchymal stem cells: the potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation.
Zhao JW; Gao ZL; Mei H; Li YL; Wang Y
Am J Med Sci; 2011 Jun; 341(6):460-8. PubMed ID: 21289500
[TBL] [Abstract][Full Text] [Related]
22. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
Tanaka Y
Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
[TBL] [Abstract][Full Text] [Related]
23. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.
Melville KM; Kelly NH; Khan SA; Schimenti JC; Ross FP; Main RP; van der Meulen MC
J Bone Miner Res; 2014 Feb; 29(2):370-9. PubMed ID: 24038209
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
25. T-Cell Mediated Inflammation in Postmenopausal Osteoporosis.
Wu D; Cline-Smith A; Shashkova E; Perla A; Katyal A; Aurora R
Front Immunol; 2021; 12():687551. PubMed ID: 34276675
[TBL] [Abstract][Full Text] [Related]
26. Roles of TNF-α, GSK-3β and RANKL in the occurrence and development of diabetic osteoporosis.
Qi J; Hu KS; Yang HL
Int J Clin Exp Pathol; 2015; 8(10):11995-2004. PubMed ID: 26722385
[TBL] [Abstract][Full Text] [Related]
27. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
28. Cytokines in the pathogenesis of osteoporosis.
Romas E; Martin TJ
Osteoporos Int; 1997; 7 Suppl 3():S47-53. PubMed ID: 9536302
[No Abstract] [Full Text] [Related]
29. Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders.
Wang T; He C; Yu X
Curr Drug Targets; 2017; 18(14):1664-1675. PubMed ID: 28056748
[TBL] [Abstract][Full Text] [Related]
30. Osteocyte biology: its implications for osteoporosis.
Bonewald LF
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):101-4. PubMed ID: 15615083
[TBL] [Abstract][Full Text] [Related]
31. Unraveling estrogen action in osteoporosis.
Krum SA; Brown M
Cell Cycle; 2008 May; 7(10):1348-52. PubMed ID: 18418063
[TBL] [Abstract][Full Text] [Related]
32. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
33. TNF-α contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation.
Zha L; He L; Liang Y; Qin H; Yu B; Chang L; Xue L
Biomed Pharmacother; 2018 Jun; 102():369-374. PubMed ID: 29571022
[TBL] [Abstract][Full Text] [Related]
34. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis.
D'Amelio P; Grimaldi A; Di Bella S; Brianza SZM; Cristofaro MA; Tamone C; Giribaldi G; Ulliers D; Pescarmona GP; Isaia G
Bone; 2008 Jul; 43(1):92-100. PubMed ID: 18407820
[TBL] [Abstract][Full Text] [Related]
35. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
36. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
[TBL] [Abstract][Full Text] [Related]
37. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.
Hughes DE; Dai A; Tiffee JC; Li HH; Mundy GR; Boyce BF
Nat Med; 1996 Oct; 2(10):1132-6. PubMed ID: 8837613
[TBL] [Abstract][Full Text] [Related]
38. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.
Stubelius A; Andersson A; Holmdahl R; Ohlsson C; Islander U; Carlsten H
BMC Musculoskelet Disord; 2016 Nov; 17(1):464. PubMed ID: 27829407
[TBL] [Abstract][Full Text] [Related]
39. Proteomic Analysis of Estrogen-Mediated Signal Transduction in Osteoclasts Formation.
Xiong Q; Tang P; Gao Y; Zhang L; Ge W
Biomed Res Int; 2015; 2015():596789. PubMed ID: 26120583
[TBL] [Abstract][Full Text] [Related]
40. Estrogen deficiency, T cells and bone loss.
Pacifici R
Cell Immunol; 2008; 252(1-2):68-80. PubMed ID: 17888417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
